Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Gastrointestinal Endoscopy|January 31, 2026
Long-term outcome after endoscopic submucosal dissection for entire circumferential cT1aN0M0 esophageal squamous cell carcinomaAtsushi Inaba, Tomohiro Kadota, Keiichiro Nishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal TumorsKeigo Chida, Akihito Kawazoe, Masahito Kawazu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto, et al.
Esophagus : Official Journal of the Japan Esophageal Society|August 22, 2021
Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinomaTomohiro Kadota, Daiki Sato, Atsushi Inaba, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 15, 2025
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)Tomohiro Kadota, Rika Fujii, Shohei Koyama, et al.
Cancer Science|May 1, 2021
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancerHiroya Taniguchi, Yoshiaki Nakamura, Daisuke Kotani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)Shota Fukuoka, Hiroki Hara, Naoki Takahashi, et al.
The Oncologist|February 28, 2026
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: The BEETS (JACCRO CC‑18) studyDaisuke Kotani, Eisuke Inoue, Tadamichi Denda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal CancerRona Yaeger, Daisuke Kotani, Sebastián Mondaca, et al.
Cancer Science|March 2, 2024
Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potentialTadayoshi Hashimoto, Yoshiaki Nakamura, Saori Mishima, et al.
Pageof 9